Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Nathan H. Fowler, MD, MD Anderson Cancer Center
home
Articles
ASH 2020 Updates in Relapsed/Refractory B-Cell Lymphomas
January 22nd 2021
ASH 2020 Updates in Non-CLL B-Cell Lymphomas
January 22nd 2021
ASH 2020 Updates in CLL
January 22nd 2021
Treatment of R/R DLBCL: Beyond CAR T Therapy
September 22nd 2020
Phase 2B SADAL Trial in R/R DLBCL
September 22nd 2020
RE-MIND Study in R/R DLBCL
September 22nd 2020
L-MIND Study in R/R DLBCL
September 22nd 2020
CAR T in Transplant-Eligible and Transplant-Ineligible DLBCL
September 22nd 2020
Standard of Care for Relapsed/Refractory DLBCL
September 22nd 2020
Closing Thoughts on Treatment of R/R DLBCL
July 15th 2020
Improving Outcomes in Patients With R/R DLBCL
July 15th 2020
Emerging Therapies for R/R DLBCL
July 15th 2020
Safety and Efficacy of Oral Agents in R/R DLBCL
July 15th 2020
Treatment of R/R DLBCL: CD19-Directed Therapy vs CAR T
July 15th 2020
CD19-Directed Therapies for Treatment of R/R DLBCL
July 15th 2020
CAR T in R/R DLBCL: Safety and Patient Selection
July 15th 2020
ASCO 2020 Data: CAR T in R/R DLBCL
July 15th 2020
Role of CAR T-cell Therapy in R/R DLBCL
July 15th 2020
Treatment in Transplant-ineligible R/R DLBCL
July 15th 2020
Prognosis of R/R DLBCL
July 15th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE